# Pharmacokinetics - Pharmacodynamic Study of HT-2157 in Healthy Subjects and in Patients With Major Depressive Disorder

> **NCT01413932** · PHASE1,PHASE2 · COMPLETED · sponsor: **Dart NeuroScience, LLC** · enrollment: 26 (actual)

## Conditions studied

- Healthy Volunteers (Part 1)
- Major Depressive Disorder (Part 2)

## Interventions

- **DRUG:** HT-2157
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01413932
- **Lead sponsor:** Dart NeuroScience, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-07
- **Primary completion:** 2012-12
- **Final completion:** 2012-12
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2015-12-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01413932

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01413932, "Pharmacokinetics - Pharmacodynamic Study of HT-2157 in Healthy Subjects and in Patients With Major Depressive Disorder". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01413932. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*